留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

临床腋窝淋巴结阳性老年三阴性乳腺癌局部治疗策略

赵佳琳 林燕 王常珺 徐颖 孙强

赵佳琳, 林燕, 王常珺, 徐颖, 孙强. 临床腋窝淋巴结阳性老年三阴性乳腺癌局部治疗策略[J]. 协和医学杂志, 2019, 10(3): 293-298. doi: 10.3969/j.issn.1674-9081.2019.03.019
引用本文: 赵佳琳, 林燕, 王常珺, 徐颖, 孙强. 临床腋窝淋巴结阳性老年三阴性乳腺癌局部治疗策略[J]. 协和医学杂志, 2019, 10(3): 293-298. doi: 10.3969/j.issn.1674-9081.2019.03.019
Jia-lin ZHAO, Yan LIN, Chang-jun WANG, Ying XU, Qiang SUN. Locoregional Treatment of Elderly Patients with Triple Negative Breast Cancer and Clinically Positive Axillary Lymph Nodes[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 293-298. doi: 10.3969/j.issn.1674-9081.2019.03.019
Citation: Jia-lin ZHAO, Yan LIN, Chang-jun WANG, Ying XU, Qiang SUN. Locoregional Treatment of Elderly Patients with Triple Negative Breast Cancer and Clinically Positive Axillary Lymph Nodes[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 293-298. doi: 10.3969/j.issn.1674-9081.2019.03.019

临床腋窝淋巴结阳性老年三阴性乳腺癌局部治疗策略

doi: 10.3969/j.issn.1674-9081.2019.03.019
基金项目: 

北京市科学技术委员会重大专项科技计划 D161100000816005

详细信息
    通讯作者:

    孙强 电话:010-69158720, E-mail:sunqiangpumc@sina.com

  • 中图分类号: R737.9

Locoregional Treatment of Elderly Patients with Triple Negative Breast Cancer and Clinically Positive Axillary Lymph Nodes

More Information
  • 摘要: 因老年乳腺癌患者多伴发基础疾病, 在选择局部治疗方案时, 除应考虑原发肿瘤本身因素外, 还需评估患者重要器官功能及其对治疗的耐受能力。三阴性乳腺癌与其他亚型乳腺癌相比, 主要表现为侵袭性强、预后不佳; 而临床腋窝淋巴结阳性的老年三阴性乳腺癌患者, 局部治疗的选择则更为棘手, 对于此类特殊群体, 尚需探索更为合理的个体化治疗方案。
    利益冲突  无
  • [1] Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer:updated recommenda-tions of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)[J]. Lancet Oncol, 2012, 13:e148-e160. doi:  10.1016/S1470-2045(11)70383-7
    [2] 张萍, 徐兵河, 马飞, 等.老年三阴性乳腺癌临床病理特征及预后分析[J].中国肿瘤临床与康复, 2010, 17:390-393. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgzllcykf201005002
    [3] 郑莹, 吴春晓, 张敏璐.乳腺癌在中国的流行状况和疾病特征[J].中国癌症杂志, 2013, 23:561-569. doi:  10.3969/j.issn.1007-3969.2013.08.001
    [4] 中国老年乳腺癌诊疗共识专家组.中国老年乳腺癌诊疗专家共识(2018版)[J].协和医学杂志, 2018, 9:196-201. https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=XHYX201804005
    [5] Schonberg MA, Marcantonio ER, Li D, et al. Breast cancer among the oldest old:tumor characteristics, treatment choices, and survival[J]. J Clin Oncol, 2010, 28:2038-2045. doi:  10.1200/JCO.2009.25.9796
    [6] Jenkins EO, Deal AM, Anders CK, et al. Age-specific changes in intrinsic breast cancer subtypes:a focus on older women[J]. Oncologist, 2014, 19:1076-1083. doi:  10.1634/theoncologist.2014-0184
    [7] 高静.老年三阴性乳腺癌的临床病理特征及治疗[J].国际肿瘤学杂志, 2013, 40:921-923. doi:  10.3760/cma.j.issn.1673-422X.2013.12.013
    [8] Karuturi M, Vanderwalde N, Muss H. Approach and Management of Breast Cancer in the Elderly[J]. Clin Geriatr Med, 2016, 32:133-53. doi:  10.1016/j.cger.2015.08.011
    [9] Ma CD, Zhou Q, Nie XQ, et al. Breast cancer in Chinese elderly women:Pathological and clinical characteristics and factors influencing treatment patterns[J]. Crit Rev Oncol Hematol, 2009, 71:258-265. doi:  10.1016/j.critrevonc.2008.11.005
    [10] Jolly TA, Williams GR, Bushan S, et al. Adjuvant treatment for older women with invasive breast cancer[J]. Womens Health, 2016, 12:129-146. https://pubmed.ncbi.nlm.nih.gov/26767315/
    [11] 张保宁, 张慧明.老年人乳腺癌治疗的研究现状与展望[J].中华肿瘤杂志, 2008, 30:161-164. doi:  10.3321/j.issn:0253-3766.2008.03.001
    [12] Sierink JC, Castro SMMD, Russell NS, et al. Treatment strategies in elderly breast cancer patients:Is there a need for surgery?[J]. Breast, 2014, 23:793-798. doi:  10.1016/j.breast.2014.08.006
    [13] Cortadellas T, Córdoba O, Gascón A, et al. Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution[J]. Eur J Surg Oncol, 2015, 41:635-640. doi:  10.1016/j.ejso.2015.01.027
    [14] Carter SA, Lyons GR, Kuerer HM, et al. Operative and oncologic outcomes in 9861 patients with operable breast cancer:single-institution analysis of breast conservation with oncoplastic reconstruction[J]. Ann Surg Oncol, 2016, 23:3190-3198. doi:  10.1245/s10434-016-5407-9
    [15] Swanick CW, Lei X, Xu Y, et al. Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors:A Population-Based Survey Study[J]. Int J Radiat Oncol Biol Phys, 2018, 100:882. doi:  10.1016/j.ijrobp.2017.11.047
    [16] 林燕, 孙强, 管珩, 等.老年乳腺癌的手术方式选择[J].中国医学科学院学报, 2012, 34:605-608. doi:  10.3881/j.issn.1000-503X.2012.06.013
    [17] Curigliano G, Burstein HJ, P Winer E, et al. De-escalating and escalating treatments for early-stage breast cancer:the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017[J]. Ann Oncol, 2017, 28:1700-1712. doi:  10.1093/annonc/mdx308
    [18] Qiu JD, Xue XY, Li R, et al. Clinicopathological features and prognosis of triple-negative breast cancer:a comparison between younger (< 60) and elderly (≥ 60) patients[J]. Eur J Cancer Care, 2016, 25:1065-1075. doi:  10.1111/ecc.12346
    [19] Chen QX, Wang XX, Lin PY, et al. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer:a population-based study from the SEER 18 database[J]. Oncotarget, 2017, 8:4773-4780. doi:  10.18632/oncotarget.13976
    [20] Angarita FA, Acuna SA, McCready DR, et al. Management of positive margins after initial lumpectomy in elderly women with breast cancer[J]. Eur J Surg Oncol, 2018, 44:1048-1053. doi:  10.1016/j.ejso.2018.02.011
    [21] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017版)[J].中国癌症杂志, 2017, 27:695-760. https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=ZGAZ201709004
    [22] Shachar SS, Jolly TA, Jones E, et al. Management of Triple-Negative Breast Cancer in Older Patients:How Is It Different?[J]. Oncology, 2018, 32:58-63.
    [23] Kunkler IH, Williams LJ, Jack WJL, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME Ⅱ):a randomised controlled trial[J]. Lancet Oncol, 2015, 16:266-273. doi:  10.1016/S1470-2045(14)71221-5
    [24] Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer:long-term follow-up of CALGB 9343[J]. J Clin Oncol, 2013, 31:2382. doi:  10.1200/JCO.2012.45.2615
    [25] Haque W, Yuan DMK, Verma V, et al. Radiation therapy utilization and outcomes for older women with breast cancer:Impact of molecular subtype and tumor grade[J]. Breast, 2017, 35:34-41. doi:  10.1016/j.breast.2017.06.011
    [26] 黄薇.放疗对老年早期乳腺癌预后的影响——基于SEER数据库的大样本回顾性研究[D].济南: 山东大学, 2018.
    [27] 王淑莲, 李晔雄, 宋永文, 等.中高危老年乳腺癌患者改良根治术后放疗的意义[J].中华肿瘤杂志, 2009, 31:863-866. doi:  10.3760/cma.j.issn.0253-3766.2009.11.014
    [28] Horton JK, Jagsi R, Woodward WA, et al. Breast Cancer Biology:Clinical Implications for Breast Radiation Therapy[J]. Int J Radiat Oncol Biol Phys, 2018, 100:23-37. doi:  10.1016/j.ijrobp.2017.08.025
    [29] Freedman RA, Foster JC, Seisler DK, et al. Accrual of older patients with breast cancer to alliance systemic therapy trials over time:protocol A151527[J]. J Clin Oncol, 2017, 35:421. https://pubmed.ncbi.nlm.nih.gov/27992272/
    [30] 周斌, 辛灵, 程元甲, 等. AJCC第8版乳腺癌预后分期重大更新及临床意义[J].协和医学杂志, 2017, 8:235-238. doi:  10.3969/j.issn.1674-9081.2017.05.008
  • 加载中
计量
  • 文章访问数:  289
  • HTML全文浏览量:  63
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-10-15
  • 刊出日期:  2020-09-18

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!